{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T12:45:49Z","timestamp":1648989949511},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,9,22]],"date-time":"2007-09-22T00:00:00Z","timestamp":1190419200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1007\/s00292-007-0942-6","type":"journal-article","created":{"date-parts":[[2007,9,20]],"date-time":"2007-09-20T06:22:32Z","timestamp":1190269352000},"page":"474-478","source":"Crossref","is-referenced-by-count":1,"title":["Molekulare Heterogenit\u00e4t maligner Melanome"],"prefix":"10.1007","volume":"28","author":[{"given":"K.","family":"Glatz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,9,22]]},"reference":[{"key":"942_CR1","first-page":"1968","volume":"60","author":"Bastian","year":"2000","unstructured":"Bastian BC, Kashani-Sabet M, Hamm H et al. (2000) Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res 60: 1968\u20131973","journal-title":"Cancer Res"},{"key":"942_CR2","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0002-9440(10)63536-5","volume":"163","author":"Bastian","year":"2003","unstructured":"Bastian BC, Olshen AB, LeBoit PE, Pinkel D (2003) Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol 163: 1765\u20131770","journal-title":"Am J Pathol"},{"key":"942_CR3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1529-8019.2005.00055.x","volume":"19","author":"Bauer","year":"2006","unstructured":"Bauer J, Bastian BC (2006) Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool. Dermatol Ther 19: 40\u201349","journal-title":"Dermatol Ther"},{"key":"942_CR4","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/cncr.22273","volume":"107","author":"Becker","year":"2006","unstructured":"Becker JC, Kirkwood JM, Agarwala SS et al. (2006) Molecularly targeted therapy for melanoma: current reality and future options. Cancer 107: 2317\u20132327","journal-title":"Cancer"},{"key":"942_CR5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1200\/JCO.2005.03.6913","volume":"24","author":"Bergsland","year":"2006","unstructured":"Bergsland EK (2006) When does the presence of the target predict response to the targeted agent? J Clin Oncol 24: 213\u2013216","journal-title":"J Clin Oncol"},{"key":"942_CR6","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/35020115","volume":"406","author":"Bittner","year":"2000","unstructured":"Bittner M, Meltzer P, Chen Y et al. (2000) Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406: 536\u2013540","journal-title":"Nature"},{"key":"942_CR7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/(SICI)1097-0215(20000301)85:5<627::AID-IJC5>3.0.CO;2-Y","volume":"85","author":"Bulliard","year":"2000","unstructured":"Bulliard JL (2000) Site-specific risk of cutaneous malignant melanoma and pattern of sun exposure in New Zealand. Int J Cancer 85: 627\u2013632","journal-title":"Int J Cancer"},{"key":"942_CR8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jaad.2004.08.034","volume":"52","author":"Carlson","year":"2005","unstructured":"Carlson JA, Ross JS, Slominski A et al. (2005) Molecular diagnostics in melanoma. J Am Acad Dermatol 52: 743\u2013775; quiz 775\u2013748","journal-title":"J Am Acad Dermatol"},{"key":"942_CR9","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrc1145","volume":"3","author":"Chin","year":"2003","unstructured":"Chin L (2003) The genetics of malignant melanoma: lessons from mouse and man. Nat Rev Cancer 3: 559\u2013570","journal-title":"Nat Rev Cancer"},{"key":"942_CR10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/(SICI)1096-9896(200006)191:2<112::AID-PATH592>3.0.CO;2-N","volume":"191","author":"Cree","year":"2000","unstructured":"Cree IA (2000) Cell cycle and melanoma\u2013two different tumours from the same cell type. J Pathol 191: 112\u2013114","journal-title":"J Pathol"},{"key":"942_CR11","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","volume":"24","author":"Curtin","year":"2006","unstructured":"Curtin JA, Busam K, Pinkel D, Bastian BC (2006) Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 24: 4340\u20134346","journal-title":"J Clin Oncol"},{"key":"942_CR12","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","volume":"353","author":"Curtin","year":"2005","unstructured":"Curtin JA, Fridlyand J, Kageshita T et al. (2005) Distinct sets of genetic alterations in melanoma. N Engl J Med 353: 2135\u20132147","journal-title":"N Engl J Med"},{"key":"942_CR13","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1200\/JCO.2005.07.168","volume":"23","author":"Dai","year":"2005","unstructured":"Dai DL, Martinka M, Li G (2005) Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases. J Clin Oncol 23: 1473\u20131482","journal-title":"J Clin Oncol"},{"key":"942_CR14","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C et al. (2002) Mutations of the BRAF gene in human cancer. Nature 417: 949\u2013954","journal-title":"Nature"},{"key":"942_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1040-7952(97)80004-3","volume":"31","author":"Downward","year":"1997","unstructured":"Downward J (1997) Role of phosphoinositide-3-OH kinase in Ras signaling. Adv Second Messenger Phosphoprotein Res 31: 1-10","journal-title":"Adv Second Messenger Phosphoprotein Res"},{"key":"942_CR16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/01.cmr.0000232300.22032.86","volume":"16","author":"Edlundh-Rose","year":"2006","unstructured":"Edlundh-Rose E, Egyha Zi S, Omholt K et al. (2006) NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing. Melanoma Res 16: 471\u2013478","journal-title":"Melanoma Res"},{"key":"942_CR17","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/sj.bjc.6600919","volume":"88","author":"Edmunds","year":"2003","unstructured":"Edmunds SC, Cree IA, Di Nicolantonio F et al. (2003) Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomas. Br J Cancer 88: 1403\u20131405","journal-title":"Br J Cancer"},{"key":"942_CR18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/jmg.2003.016667","volume":"41","author":"Edwards","year":"2004","unstructured":"Edwards RH, Ward MR, Wu H et al. (2004) Absence of BRAF mutations in UV-protected mucosal melanomas. J Med Genet 41: 270\u2013272","journal-title":"J Med Genet"},{"key":"942_CR19","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S1470-2045(03)01280-4","volume":"4","author":"Eigentler","year":"2003","unstructured":"Eigentler TK, Caroli UM, Radny P, Garbe C (2003) Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials. Lancet Oncol 4: 748\u2013759","journal-title":"Lancet Oncol"},{"key":"942_CR20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/(SICI)1097-0215(19971009)73:2<198::AID-IJC6>3.0.CO;2-R","volume":"73","author":"Elwood","year":"1997","unstructured":"Elwood JM, Jopson J (1997) Melanoma and sun exposure: an overview of published studies. Int J Cancer 73: 198\u2013203","journal-title":"Int J Cancer"},{"key":"942_CR21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature03664","volume":"436","author":"Garraway","year":"2005","unstructured":"Garraway LA, Widlund HR, Rubin MA et al. (2005) Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436: 117\u2013122","journal-title":"Nature"},{"key":"942_CR22","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00428-006-0167-8","volume":"449","author":"Glatz-Krieger","year":"2006","unstructured":"Glatz-Krieger K, Pache M, Tapia C et al. (2006) Anatomic site-specific patterns of gene copy number gains in skin, mucosal, and uveal melanomas detected by fluorescence in situ hybridization. Virchows Arch 449: 328\u2013333","journal-title":"Virchows Arch"},{"key":"942_CR23","first-page":"3660","volume":"57","author":"Guldberg","year":"1997","unstructured":"Guldberg P, Straten P thor, Birck A et al. (1997) Disruption of the MMAC1\/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 57: 3660\u20133663","journal-title":"Cancer Res"},{"key":"942_CR24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.dad.0000187931.05030.a0","volume":"28","author":"Ishihara","year":"2006","unstructured":"Ishihara Y, Saida T, Miyazaki A et al. (2006) Early acral melanoma in situ: correlation between the parallel ridge pattern on dermoscopy and microscopic features. Am J Dermatopathol 28: 21\u201327","journal-title":"Am J Dermatopathol"},{"key":"942_CR25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/gcc.2870080307","volume":"8","author":"Isshiki","year":"1993","unstructured":"Isshiki K, Elder DE, Guerry D, Linnenbach AJ (1993) Chromosome 10 allelic loss in malignant melanoma. Genes Chromosomes Cancer 8: 178\u2013184","journal-title":"Genes Chromosomes Cancer"},{"key":"942_CR26","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1038\/sj.onc.1206450","volume":"22","author":"Jhappan","year":"2003","unstructured":"Jhappan C, Noonan FP, Merlino G (2003) Ultraviolet radiation and cutaneous malignant melanoma. Oncogene 22: 3099\u20133112","journal-title":"Oncogene"},{"key":"942_CR27","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1126\/science.1072682","volume":"298","author":"Johnson","year":"2002","unstructured":"Johnson GL, Lapadat R (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911\u20131912","journal-title":"Science"},{"key":"942_CR28","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1167\/iovs.06-0101","volume":"47","author":"Kilic","year":"2006","unstructured":"Kilic E, Gils W van, Lodder E et al. (2006) Clinical and cytogenetic analyses in uveal melanoma. Invest Ophthalmol Vis Sci 47: 3703\u20133707","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"942_CR29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.0022-202X.2005.23833.x","volume":"125","author":"Lang","year":"2005","unstructured":"Lang J, MacKie RM (2005) Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral, and lentigo maligna subtypes. J Invest Dermatol 125: 575\u2013579","journal-title":"J Invest Dermatol"},{"key":"942_CR30","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/cncr.22126","volume":"107","author":"Lasithiotakis","year":"2006","unstructured":"Lasithiotakis KG, Leiter U, Gorkievicz R et al. (2006) The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003. Cancer 107: 1331\u20131339","journal-title":"Cancer"},{"key":"942_CR31","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.molmed.2006.07.008","volume":"12","author":"Levy","year":"2006","unstructured":"Levy C, Khaled M, Fisher DE (2006) MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 12: 406\u2013414","journal-title":"Trends Mol Med"},{"key":"942_CR32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1083\/jcb.200410115","volume":"168","author":"Loercher","year":"2005","unstructured":"Loercher AE, Tank EM, Delston RB, Harbour JW (2005) MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A. J Cell Biol 168: 35\u201340","journal-title":"J Cell Biol"},{"key":"942_CR33","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/jnci\/djg123","volume":"95","author":"Maldonado","year":"2003","unstructured":"Maldonado JL, Fridlyand J, Patel H et al. (2003) Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 95: 1878\u20131890","journal-title":"J Natl Cancer Inst"},{"key":"942_CR34","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nature03890","volume":"436","author":"Michaloglou","year":"2005","unstructured":"Michaloglou C, Vredeveld LC, Soengas MS et al. (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436: 720\u2013724","journal-title":"Nature"},{"key":"942_CR35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJMra052166","volume":"355","author":"Miller","year":"2006","unstructured":"Miller AJ, Mihm MC Jr (2006) Melanoma. N Engl J Med 355: 51\u201365","journal-title":"N Engl J Med"},{"key":"942_CR36","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0898-6568(01)00271-6","volume":"14","author":"Nicholson","year":"2002","unstructured":"Nicholson KM, Anderson NG (2002) The protein kinase B\/Akt signalling pathway in human malignancy. Cell Signal 14: 381\u2013395","journal-title":"Cell Signal"},{"key":"942_CR37","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00428-003-0883-2","volume":"443","author":"Pache","year":"2003","unstructured":"Pache M, Glatz K, Bosch D et al. (2003) Sequence analysis and high-throughput immunhistochemical profiling of KIT (CD 117) expression in uveal melanoma using tissue microarrays. Virchows Arch 443: 741\u2013744","journal-title":"Virchows Arch"},{"key":"942_CR38","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.0303-6987.2003.00179.x","volume":"31","author":"Palmedo","year":"2004","unstructured":"Palmedo G, Hantschke M, Rutten A et al. (2004) The T1796A mutation of the BRAF gene is absent in Spitz nevi. J Cutan Pathol 31: 266\u2013270","journal-title":"J Cutan Pathol"},{"key":"942_CR39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1054","volume":"33","author":"Pollock","year":"2003","unstructured":"Pollock PM, Harper UL, Hansen KS et al. (2003) High frequency of BRAF mutations in nevi. Nat Genet 33: 19\u201320","journal-title":"Nat Genet"},{"key":"942_CR40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s004280050477","volume":"436","author":"Reifenberger","year":"2000","unstructured":"Reifenberger J, Wolter M, Bostrom J et al. (2000) Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas. Virchows Arch 436: 487\u2013493","journal-title":"Virchows Arch"},{"key":"942_CR41","first-page":"185","volume":"222","author":"Satyamoorthy","year":"2003","unstructured":"Satyamoorthy K, Herlyn M (2003) p16INK4A and familial melanoma. Methods Mol Biol 222: 185\u2013195","journal-title":"Methods Mol Biol"},{"key":"942_CR42","first-page":"3200","volume":"62","author":"Sauter","year":"2002","unstructured":"Sauter ER, Yeo UC, Stemm A von et al. (2002) Cyclin D1 is a candidate oncogene in cutaneous melanoma. Cancer Res 62: 3200\u20133206","journal-title":"Cancer Res"},{"key":"942_CR43","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/(SICI)1098-2264(199705)19:1<22::AID-GCC4>3.0.CO;2-2","volume":"19","author":"Sisley","year":"1997","unstructured":"Sisley K, Rennie IG, Parsons MA et al. (1997) Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosomes Cancer 19: 22\u201328","journal-title":"Genes Chromosomes Cancer"},{"key":"942_CR44","doi-asserted-by":"crossref","first-page":"7002","DOI":"10.1158\/0008-5472.CAN-04-1399","volume":"64","author":"Stahl","year":"2004","unstructured":"Stahl JM, Sharma A, Cheung M et al. (2004) Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Res 64: 7002\u20137010","journal-title":"Cancer Res"},{"key":"942_CR45","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1047-2797(03)00002-4","volume":"13","author":"Stang","year":"2003","unstructured":"Stang A, Jockel KH (2003) Changing patterns of skin melanoma mortality in West Germany from 1968 through 1999. Ann Epidemiol 13: 436\u2013442","journal-title":"Ann Epidemiol"},{"key":"942_CR46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.cmr.0000215035.38436.87","volume":"16","author":"Thomas","year":"2006","unstructured":"Thomas NE (2006) BRAF somatic mutations in malignant melanoma and melanocytic naevi. Melanoma Res 16: 97\u2013103","journal-title":"Melanoma Res"},{"key":"942_CR47","first-page":"1800","volume":"60","author":"Tsao","year":"2000","unstructured":"Tsao H, Zhang X, Fowlkes K, Haluska FG (2000) Relative reciprocity of NRAS and PTEN\/MMAC1 alterations in cutaneous melanoma cell lines. Cancer Res 60: 1800\u20131804","journal-title":"Cancer Res"},{"key":"942_CR48","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/1097-0142(19850315)55:6<1398::AID-CNCR2820550639>3.0.CO;2-A","volume":"55","author":"Urist","year":"1985","unstructured":"Urist MM, Balch CM, Soong S et al. (1985) The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma. Cancer 55: 1398\u20131402","journal-title":"Cancer"},{"key":"942_CR49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/gcc.10156","volume":"36","author":"Dijk","year":"2003","unstructured":"Dijk M van, Sprenger S, Rombout P et al. (2003) Distinct chromosomal aberrations in sinonasal mucosal melanoma as detected by comparative genomic hybridization. Genes Chromosomes Cancer 36: 151\u2013158","journal-title":"Genes Chromosomes Cancer"},{"key":"942_CR50","first-page":"M21","volume":"1470","author":"Vazquez","year":"2000","unstructured":"Vazquez F, Sellers WR (2000) The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling. Biochim Biophys Acta 1470: M21\u2013M35","journal-title":"Biochim Biophys Acta"},{"key":"942_CR51","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/archderm.141.8.963","volume":"141","author":"Warthan","year":"2005","unstructured":"Warthan MM, Uchida T, Wagner RF Jr (2005) UV light tanning as a type of substance-related disorder. Arch Dermatol 141: 963\u2013966","journal-title":"Arch Dermatol"},{"key":"942_CR52","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/(SICI)1097-0215(19980911)77:6<843::AID-IJC8>3.0.CO;2-U","volume":"77","author":"Whiteman","year":"1998","unstructured":"Whiteman DC, Parsons PG, Green AC (1998) p53 expression and risk factors for cutaneous melanoma: a case-control study. Int J Cancer 77: 843\u2013848","journal-title":"Int J Cancer"},{"key":"942_CR53","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/jnci\/95.11.806","volume":"95","author":"Whiteman","year":"2003","unstructured":"Whiteman DC, Watt P, Purdie DM et al. (2003) Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst 95: 806\u2013812","journal-title":"J Natl Cancer Inst"},{"key":"942_CR54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1023\/A:1008980919928","volume":"12","author":"Whiteman","year":"2001","unstructured":"Whiteman DC, Whiteman CA, Green AC (2001) Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 12: 69\u201382","journal-title":"Cancer Causes Control"},{"key":"942_CR55","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","volume":"64","author":"Wilhelm","year":"2004","unstructured":"Wilhelm SM, Carter C, Tang L et al. (2004) BAY 43\u20139006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res 64: 7099\u20137109","journal-title":"Cancer Res"},{"key":"942_CR56","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/sj.bjc.6602598","volume":"92","author":"Zuidervaart","year":"2005","unstructured":"Zuidervaart W, Nieuwpoort F van, Stark M et al. (2005) Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS. Br J Cancer 92: 2032\u20132038","journal-title":"Br J Cancer"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-007-0942-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-007-0942-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-007-0942-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:00:58Z","timestamp":1559041258000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-007-0942-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,22]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["942"],"URL":"https:\/\/doi.org\/10.1007\/s00292-007-0942-6","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,22]]}}}